Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Published Date: 11 Sep 2024

The c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an acceptable safety profile in patients of Asian race with c-Met protein-overexpressing, epidermal growth factor receptor ...

Read Full News

Latest News

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

News All Time

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

However, rates were improved from previous survey results

FDA Says First 'Real-Time' Clinical Trial Is Underway

Two sponsors are on board, with a larger pilot program planned later this year

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

Mim8 prophylaxis significantly reduced bleeding events in patients with or without inhibitors

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Three-fourths of patients had cancer-free mediastinal lymph nodes, clear surgical margins in 93%

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers

FDA Panel Endorses Capivasertib Use in Prostate Cancer

Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful"

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

News, features, and commentary about cancer-related issues

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

His death followed a hospitalization for cancer treatment side effects

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Here's what two brain surgeries taught me about public health and care access

Woman Loses 6-Year Battle With Mouth Tumor

Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions

Why Did Rare Cancer Shrink on Its Own?

Case illustrates the mystery of spontaneous regression

Oncologist on Hantavirus Cruise; Bile Duct Cancer Drug OK'd; Untreated Lung Cancers

News, features, and commentary about cancer-related issues

What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?

The cause lies in a lengthy history of cancer treatment, confirmed by histopathology analysis

What Do Patients Want Doctors to Know About Breast Cancer Recurrence?

What Do Patients Want Doctors to Know About Breast Cancer Recurrence?

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

Deaths directly attributed to vitamin K deficiency bleeding have started to climb in recent years

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Recommended News For You

Survey shows cancer anxiety has impact well beyond the individual diagnosed

Relationship-building key to addressing oncologist shortages in rural care

Approved BTK Inhibitor Without Covalent Bond for CLL.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

Women are more susceptible to the stress caused by inflation.

Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests

Recommended Articles For You

Ultimate Guide to Oncology Services in the USA 

Bridging Heart and Cancer Care: The Essential Framework of a Modern Cardio-Oncology Program 

Clinical Analysis of Prostate Cancer 

Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.

2.

Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.

3.

FDA approves Blenrep for relapsed or refractory multiple myeloma

4.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

5.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

1.

Understanding Iron Saturation Levels in Your Blood 

2.

Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges

3.

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies

4.

How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?

5.

Unveiling the Mystery of Castleman's Disease: A Journey to Better Health

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

3.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

4.

Navigating the Complexities of Ph Negative ALL - Part XIV

5.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot